Seven @ Seven

Voters in four states cast primary ballots Tuesday in the first significant electoral test of the 2026 cycle. Maine's Senate primary is the headline contest, with the seat considered critical to control of the upper chamber. Republican incumbents in Maine and Nevada are facing serious challenges from Trump-aligned insurgents, while South Carolina Republicans pick among a crowded slate of MAGA-devoted candidates vying to be the next governor.

The backdrop is a president actively undermining confidence in elections. Trump again leveled baseless fraud claims against California — claims a former state election official methodically debunked on PBS NewsHour. Democrats are not standing by: American Bridge announced a $50 million ad blitz targeting Republicans in deep-red districts the party believes are newly vulnerable amid economic anxiety, war fatigue and SNAP cuts that have stripped benefits from 3.5 million people.

Downballot, the realignment is stark. In Los Angeles, progressive councilmember Nithya Raman knocked Republican reality star Spencer Pratt out of the mayoral runoff, setting up a November race against incumbent Karen Bass. In Texas, Dan Cogdell — the attorney who defended Ken Paxton in his 2023 impeachment trial — endorsed Democrat James Talarico over Paxton in the Senate race, calling Paxton too close to Trump. Polling shows that race within the margin of error.

OpenAI on Monday confirmed it filed confidential paperwork with the Securities and Exchange Commission for a potential initial public offering. 'We expect it to leak so we're just announcing it,' the company said, in characteristically casual fashion for a firm valued at $852 billion. CEO Sam Altman had floated an IPO last fall as the 'most likely path' given the company's enormous capital needs.

The filing makes OpenAI the third AI-adjacent giant racing to Wall Street: Anthropic disclosed IPO plans on June 1, and Elon Musk's SpaceX is already on a roadshow pitching itself as an AI-focused space company. All three are losing money at scale. OpenAI has not disclosed revenues or a timeline to profitability. The path was paved last year when the company restructured as a public benefit corporation under nonprofit control, and cleared in May when a federal jury sided with OpenAI in Musk's lawsuit seeking to unwind the conversion.

The IPO comes at what Emarketer's Nate Elliott calls a 'precarious moment.' ChatGPT's early consumer dominance is eroding to Google's Gemini and Anthropic's Claude, while training costs balloon. Public markets give OpenAI access to capital it cannot raise privately at current scale — but also subject it to disclosure requirements that will, for the first time, force a clear-eyed look at whether the economics of generative AI actually work.

The economic bill for the Iran war is landing. New federal data show U.S. airlines spent nearly $6.5 billion on jet fuel in April — a 78% jump from a year earlier — as the closure of the Strait of Hormuz throttled global crude flows. The International Air Transport Association slashed its global airline profit outlook in response. Gas prices at the pump have soared, and Trump is publicly hammering for a deal partly to relieve that pressure before November's midterms.

Markets are trying to look past it. The S&P 500 climbed for a second day Tuesday on an AI-led rebound, with copper and other industrial metals rising as Middle East tensions appeared to ease. Kuwait offered oil to Asian buyers for the first time since the war began — a tentative sign that Gulf supply chains are limping back to life. But a planned $799 million Saudi IPO was postponed citing war risk, and Goldman and Barclays traders warned clients of continued volatility after Friday's rout.

Domestically, the strain is showing. NFIB small-business optimism fell to its lowest reading since October 2024. BNP Paribas now forecasts three Federal Reserve rate hikes starting in December, citing inflation risks from energy costs and tariffs. Gold is at $4,343 an ounce, up 31% over the year — investors are still hedging hard against the geopolitical and macro tail.

Gustavo Dudamel's era in Los Angeles is ending. The Venezuelan conductor wrapped his final concerts as music and artistic director of the Los Angeles Philharmonic at Walt Disney Concert Hall this week, closing a 17-year run that began when he arrived in 2009 as a 28-year-old prodigy and reshaped the orchestra's identity.

Under Dudamel, the LA Phil became arguably the most adventurous major American orchestra — commissioning new works at a clip few peers could match, foregrounding Latin American composers, and embedding itself in the city through Youth Orchestra Los Angeles (YOLA), a free classical training program modeled on Venezuela's El Sistema, the system that produced Dudamel himself. His Hollywood Bowl performances became cultural events; his collaborations with film composers blurred lines between concert hall and pop culture.

He leaves for the New York Philharmonic, which he takes over in the 2026–27 season. The succession in Los Angeles will test whether the institution Dudamel built can sustain its momentum without the charisma that defined it. For now, the bow he took at Disney Hall was both an ending and a marker of what classical music can be when an orchestra commits fully to a city.

FIFA has revoked Iran's fan-ticket allocation for the World Cup group stage, the Iranian football federation said Tuesday, just three days before the tournament opens in the United States, Canada and Mexico. Under FIFA rules, each participating federation receives 8% of tickets for its matches to sell to its own supporters. Iran says it had already begun selling those tickets when the allocation was pulled. Some fans have already paid for travel.

'Depriving Iranian supporters of access to their lawful and official allocation of tickets is an action contrary to the spirit of governing international competitions,' the federation said, accusing FIFA of bending to 'non-sporting and political considerations.' Iran is scheduled to play New Zealand in Los Angeles on June 15, Belgium in LA on June 21 and Egypt in Seattle on June 26.

The ticket dispute is the latest indignity for Iran's World Cup campaign. The team moved its training base from Tucson to Tijuana in May, citing U.S. reluctance to host them, and under visa restrictions must fly in and out of the U.S. only on matchdays. Iran says the U.S. denied visas to 15 administrative staff. A Somali referee, Omar Abdulkadir Artan, was also denied U.S. entry, ending what would have been a historic appointment. The tournament that was sold as a unifying spectacle is becoming a barometer of how thoroughly geopolitics has colonized sport.

A government-commissioned review of alcohol's health harms — sidelined by the Trump administration after industry pressure — was published independently Tuesday in the Journal of Studies on Alcohol and Drugs. Its conclusions match years of converging science: no amount of alcohol is protective for mortality, and even 'moderate' drinking elevates the risk of premature death and more than 200 diseases, including heart disease and multiple cancers.

The study was one of two reviews commissioned under the Biden administration to inform the 2025–2030 Dietary Guidelines. The Trump administration's final guidelines softened to a vague 'less alcohol for better overall health' line, omitting the detailed risk findings. Robert Vincent, the SAMHSA official who led the effort and was laid off in a federal reduction-in-force last year, wrote in an accompanying editorial that 'what remains contested is whether evidence will meaningfully inform policy when it conflicts with commercial interests.' The alcohol industry mounted a campaign to discredit the draft last year, and the House oversight committee called the research 'fraught with bias.'

HHS spokesperson Emily Hilliard denies the study was ignored. But the episode fits a pattern: a Pew/AP-NORC-style trust collapse is underway, with only half of U.S. adults now telling pollsters they trust CDC public health recommendations. The empirical picture on alcohol has been clear for years — the WHO declared in 2023 that no safe level exists. Policy is now openly diverging from the evidence.